Takeru Furuya
Analyst-Equity en Perceptive Advisors LLC .
Cargos activos de Takeru Furuya
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Analyst-Equity | 01/02/2022 | - |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/02/2022 | - |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Inversor de Capital Privado | 01/02/2022 | - |
Historial de carrera de Takeru Furuya
Antiguos cargos conocidos de Takeru Furuya.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Corporate Officer/Principal | 01/09/2019 | 01/02/2022 |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/01/2018 | 01/09/2019 |
Ocuterra Therapeutics, Inc.
Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Ocuterra Therapeutics, Inc. manufactures drug products. The company is headquartered in Boston, MA. | Corporate Officer/Principal | 01/12/2010 | 01/01/2018 |
Formación de Takeru Furuya.
Harvard University | Doctorate Degree |
University of Tokyo | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Japón | 2 |
Operativa
Corporate Officer/Principal | 4 |
Analyst-Equity | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 4 |
Finance | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 6 |
---|---|
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Finance |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Health Technology |
Ocuterra Therapeutics, Inc.
Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Ocuterra Therapeutics, Inc. manufactures drug products. The company is headquartered in Boston, MA. | Retail Trade |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Finance |
- Bolsa de valores
- Insiders
- Takeru Furuya
- Experiencia